FIELD: medicine.
SUBSTANCE: invention is related to the field of medicine, namely to medical toxicology, microbiology, and is related to method for assessment of clinical significance of clostridia in conditions of polymicrobial infection. Method consists in the fact that standard amount of daily clostridia culture is incubated in conditions of anaerostat in SKS medium together with monolayer of human embryo skin fibroblasts, and after triple washing of monolayer cells by Eagle's medium, method of microscopy is used to assess availability and effect of toxin according to extent of monolayer damage in compliance with USA Pharmacopoeia scale.
EFFECT: higher accuracy of detection of clostridial toxins and determination of their effect.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATION OF SPECIFIC ACTIVITY OF IMMUNE PREPARATIONS | 2005 |
|
RU2291425C1 |
EVALUATION OF SORBENT SORPTION ACTIVITY | 2004 |
|
RU2298036C2 |
METHOD OF EVALUATING BACTERIAL LOAD OF URINE, PROSTATIC SECRETION, EJACULATE | 2010 |
|
RU2452773C1 |
RECOMBINANT ATTENUATED MICROORGANISMS CLOSTRIDIUM AND VACCINE | 2007 |
|
RU2445364C2 |
FORMULATION WITH STABILISED OXIDATION-REDUCTION POTENTIAL | 2012 |
|
RU2499600C1 |
ESSENTIALLY NON-TOXIC MUTEIN OF Clostridium perfringens ALPHA TOXIN AND NUCLEIC ACID MOLECULE CODING SAME | 2007 |
|
RU2593945C2 |
METHOD OF ASSESSING BACTERIOPHAGE SPECIFIC ACTIVITY USING CELL CULTURES | 2019 |
|
RU2723188C1 |
METHOD OF DETERMINING DEGREE OF EPIDEMIC HAZARD OF PATHOGENIC AND POTENTIALLY PATHOGENIC BACTERIA ISOLATED FROM WATER FOR VARIOUS USES | 2010 |
|
RU2446214C1 |
METHOD FOR PREVENTING MASTITIS | 2003 |
|
RU2239422C1 |
METHOD FOR EVALUATING SPECIFIC ACTIVITY OF BACTERIOPHAGES | 2005 |
|
RU2296163C2 |
Authors
Dates
2009-02-27—Published
2006-12-12—Filed